XML 28 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Beneficiaries' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Deferred Compensation Payable in Common Shares
Additional Paid-in Capital
Common Shares in Grantor Trust
Cumulative Earnings
Cumulative Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Cumulative Distributions
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2017     178,285,236 894,736              
Beneficiaries' Equity, beginning balance at Dec. 31, 2017 $ 1,826,870   $ 1,784 $ 12,445 $ 3,218,077 $ (12,445) $ 641,093   $ 2,399 $ (2,053,741) $ 17,258
Net income 135,472           134,518       954
Other comprehensive income 2,669               2,630   39
Issuance of Common Shares of Beneficial Interest (in shares)     23,311                
Issuance of Common Shares of Beneficial Interest $ 416       416            
Repurchase and retirement of Common Shares of Beneficial Interest (in shares) (1,729,278)   (1,729,278)                
Repurchase and retirement of Common Shares of Beneficial Interest $ (21,858)   $ (17)   (21,841)            
Issuance of partnership interest in consolidated real estate venture 16                   16
Distributions from consolidated real estate venture (94)                   (94)
Share Choice Plan Issuance (in shares)     (1,285)                
Redemption of LP Units (7,043)                   (7,043)
Share-based compensation activity (in shares)     196,151                
Share-based compensation activity 5,845   $ 2   5,829   14        
Share Issuance from/(to) Deferred Compensation Plan (in shares)     99,189 82,384              
Share Issuance from/(to) Deferred Compensation Plan (111)   $ 1 $ 1,576 (112) (1,576)          
Reallocation of Noncontrolling Interest 0       (2,057)           2,057
Distributions declared (131,154)                 (130,168) (986)
Ending balance (in shares) at Dec. 31, 2018     176,873,324 977,120              
Beneficiaries' Equity, ending balance at Dec. 31, 2018 1,811,028 $ (5,336) $ 1,770 $ 14,021 3,200,312 (14,021) 775,625 $ (5,336) 5,029 (2,183,909) 12,201
Net income 34,529           34,267       262
Other comprehensive income $ (7,440)               (7,399)   (41)
Repurchase and retirement of Common Shares of Beneficial Interest (in shares) (1,337,169)   (1,337,169)                
Repurchase and retirement of Common Shares of Beneficial Interest $ (17,281)   $ (13)   (17,268)            
Issuance of partnership interest in consolidated real estate venture 27                   27
Purchase of partnership interest in consolidated real estate venture (2,180)       (983)           (1,197)
Redemption of LP Units (in shares)     1,245                
Redemption of LP Units 0       16           (16)
Share-based compensation activity (in shares)     845,210 41,342              
Share-based compensation activity 10,027   $ 9   10,018            
Share Issuance from/(to) Deferred Compensation Plan (in shares)     97,485 87,080              
Share Issuance from/(to) Deferred Compensation Plan 0     $ 2,195   (2,195)          
Reallocation of Noncontrolling Interest 0       63           (63)
Distributions declared (135,071)                 (134,324) (747)
Ending balance (in shares) at Dec. 31, 2019     176,480,095 1,105,542              
Beneficiaries' Equity, ending balance at Dec. 31, 2019 1,688,303   $ 1,766 $ 16,216 3,192,158 (16,216) 804,556   (2,370) (2,318,233) 10,426
Net income 307,326           305,527       1,799
Other comprehensive income $ (5,220)               (5,191)   (29)
Repurchase and retirement of Common Shares of Beneficial Interest (in shares) (6,248,483)   (6,248,483)                
Repurchase and retirement of Common Shares of Beneficial Interest $ (59,999)   $ (62)   (59,937)            
Sale of partnership interest to consolidated real estate venture (1,017)                    
Distributions from consolidated real estate venture (22)                    
Share-based compensation activity (in shares)     309,096 50,967              
Share-based compensation activity 6,236   $ 3   6,233            
Share Issuance from/(to) Deferred Compensation Plan (in shares)     32,256 3,985              
Share Issuance from/(to) Deferred Compensation Plan (206)     $ 1,300 (206) (1,300)          
Reallocation of Noncontrolling Interest 0       (96)           96
Distributions declared (130,753)                 (130,005) (748)
Ending balance (in shares) at Dec. 31, 2020     170,572,964 1,160,494              
Beneficiaries' Equity, ending balance at Dec. 31, 2020 $ 1,804,648   $ 1,707 $ 17,516 $ 3,138,152 $ (17,516) $ 1,110,083   $ (7,561) $ (2,448,238) $ 10,505